Global Golimumab(Simponi) Production, Demand and Key Producers, 2022-2028

November 2022 | 84 pages | ID: GB82865A303EEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
A tumor necrosis factor (TNF)-? inhibitor

This report studies the global Golimumab(Simponi) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Golimumab(Simponi), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Golimumab(Simponi) that contribute to its increasing demand across many markets.

The global Golimumab(Simponi) market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Golimumab(Simponi) total production and demand, 2017-2028, (Box)

Global Golimumab(Simponi) total production value, 2017-2028, (USD Million)

Global Golimumab(Simponi) production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Box)

Global Golimumab(Simponi) consumption by region & country, CAGR, 2017-2028 & (Box)

U.S. VS China: Golimumab(Simponi) domestic production, consumption, key domestic manufacturers and share

Global Golimumab(Simponi) production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Box)

Global Golimumab(Simponi) production by Specification, production, value, CAGR, 2017-2028, (USD Million) & (Box)

Global Golimumab(Simponi) production by Application production, value, CAGR, 2017-2028, (USD Million) & (Box)

This reports profiles key players in the global Golimumab(Simponi) market based on the following parameters – headquarters, production locations, products portfolio, Golimumab(Simponi) revenue, sales, average price and gross margin, recent developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Golimumab(Simponi) market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Box) and average price (US$/Box) by manufacturer, by Specification, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Golimumab(Simponi) Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
Global Golimumab(Simponi) Market, Segmentation by Specification
  • 100Mg/Ml
  • 50Mg/Ml
  • 10Mg/Ml
Global Golimumab(Simponi) Market, Segmentation by Application
  • Hospital
  • Clinic
  • Other
Companies Profiled:
  • Chemieliva Pharma
  • JNJ
  • DSK Biopharma
Key Questions Answered

1. How big is the global Golimumab(Simponi) market?

2. What is the demand of the global Golimumab(Simponi) market?

3. What is the year over year growth of the global Golimumab(Simponi) market?

4. What is the production and production value of the global Golimumab(Simponi) market?

5. Who are the key producers in the global Golimumab(Simponi) market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Golimumab(Simponi) Introduction
1.2 World Golimumab(Simponi) Supply & Forecast
  1.2.1 World Golimumab(Simponi) Production Value (2017 & 2021 & 2028)
  1.2.2 World Golimumab(Simponi) Production (2017-2028)
  1.2.3 World Golimumab(Simponi) Pricing Trends (2017-2028)
1.3 World Golimumab(Simponi) Production by Region
  1.3.1 World Golimumab(Simponi) Production Value by Region (2017-2028)
  1.3.2 World Golimumab(Simponi) Production by Region (2017-2028)
  1.3.3 World Golimumab(Simponi) Average Price by Region (2017-2028)
  1.3.4 North America Golimumab(Simponi) Production (2017-2028)
  1.3.5 Europe Golimumab(Simponi) Production (2017-2028)
  1.3.6 China Golimumab(Simponi) Production (2017-2028)
  1.3.7 Japan Golimumab(Simponi) Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Golimumab(Simponi) Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Golimumab(Simponi) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Golimumab(Simponi) Demand (2017-2028)
2.2 World Golimumab(Simponi) Consumption by Region
  2.2.1 World Golimumab(Simponi) Consumption by Region (2017-2022)
  2.2.2 World Golimumab(Simponi) Consumption Forecast by Region (2023-2028)
2.3 United States Golimumab(Simponi) Consumption (2017-2028)
2.4 China Golimumab(Simponi) Consumption (2017-2028)
2.5 Europe Golimumab(Simponi) Consumption (2017-2028)
2.6 Japan Golimumab(Simponi) Consumption (2017-2028)
2.7 South Korea Golimumab(Simponi) Consumption (2017-2028)
2.8 ASEAN Golimumab(Simponi) Consumption (2017-2028)
2.9 India Golimumab(Simponi) Consumption (2017-2028)

3 WORLD GOLIMUMAB(SIMPONI) MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Golimumab(Simponi) Production Value by Manufacturer (2017-2022)
3.2 World Golimumab(Simponi) Production by Manufacturer (2017-2022)
3.3 World Golimumab(Simponi) Average Price by Manufacturer (2017-2022)
3.4 Golimumab(Simponi) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Golimumab(Simponi) Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Golimumab(Simponi) in 2021
  3.5.3 Global Concentration Ratios (CR8) for Golimumab(Simponi) in 2021
3.6 Golimumab(Simponi) Market: Overall Company Footprint Analysis
  3.6.1 Golimumab(Simponi) Market: Region Footprint
  3.6.2 Golimumab(Simponi) Market: Company Product Type Footprint
  3.6.3 Golimumab(Simponi) Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Golimumab(Simponi) Production Value Comparison
  4.1.1 United States VS China: Golimumab(Simponi) Production Value Comparison (2017 & 2021 & 2028)
  4.1.2 United States VS China: Golimumab(Simponi) Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Golimumab(Simponi) Production Comparison
  4.2.1 United States VS China: Golimumab(Simponi) Production Comparison (2017 & 2021 & 2028)
  4.2.2 United States VS China: Golimumab(Simponi) Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Golimumab(Simponi) Consumption Comparison
  4.3.1 United States VS China: Golimumab(Simponi) Consumption Comparison (2017 & 2021 & 2028)
  4.3.2 United States VS China: Golimumab(Simponi) Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Golimumab(Simponi) Key Producers and Market Share, 2017-2022
  4.4.1 Major Manufacturer of Golimumab(Simponi) in United States, Company Headquarters and Production Place (States, Country)
  4.4.2 United States Golimumab(Simponi) Production Value by Domestic Manufacturer, (2017-2022)
  4.4.3 United States Golimumab(Simponi) Production by Domestic Manufacturer, (2017-2022)
4.5 China Golimumab(Simponi) Key Producers and Market Share, 2017-2022
  4.5.1 Major Manufacturer of Golimumab(Simponi) in China, Company Headquarters and Production Place (Province, Country)
  4.5.2 China Golimumab(Simponi) Production Value by Domestic Manufacturer, (2017-2022)
  4.5.3 China Golimumab(Simponi) Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Golimumab(Simponi) Key Producers and Market Share, 2017-2022
  4.6.1 Major Manufacturer of Golimumab(Simponi) in Rest of World, Company Headquarters and Production Place (State, Country)
  4.6.2 Rest of World Golimumab(Simponi) Production Value by Domestic Manufacturer, (2017-2022)
  4.6.3 Rest of World Golimumab(Simponi) Production by Domestic Manufacturer, (2017-2022)

5 MARKET ANALYSIS BY SPECIFICATION

5.1 World Golimumab(Simponi) Market Size Overview by Specification: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Specification
  5.2.1 100Mg/Ml
  5.2.2 50Mg/Ml
  5.2.3 10Mg/Ml
5.3 Market Segment by Specification
  5.3.1 World Golimumab(Simponi) Production by Specification (2017-2028)
  5.3.2 World Golimumab(Simponi) Production Value by Specification (2017-2028)
  5.3.3 World Golimumab(Simponi) Average Price by Specification (2017-2028)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Golimumab(Simponi) Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Clinic
  6.2.3 Other
6.3 Market Segment by Application
  6.3.1 World Golimumab(Simponi) Production by Application (2017-2028)
  6.3.2 World Golimumab(Simponi) Production Value by Application (2017-2028)
  6.3.3 World Golimumab(Simponi) Average Price by Application (2017-2028)

7 COMPANY PROFILES

7.1 Chemieliva Pharma
  7.1.1 Chemieliva Pharma Details
  7.1.2 Chemieliva Pharma Major Business
  7.1.3 Chemieliva Pharma Golimumab(Simponi) Product and Services
  7.1.4 Chemieliva Pharma Golimumab(Simponi) Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.1.5 Chemieliva Pharma Recent Developments/Updates
  7.1.6 Chemieliva Pharma Competitive Strengths & Weaknesses
7.2 JNJ
  7.2.1 JNJ Details
  7.2.2 JNJ Major Business
  7.2.3 JNJ Golimumab(Simponi) Product and Services
  7.2.4 JNJ Golimumab(Simponi) Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.2.5 JNJ Recent Developments/Updates
  7.2.6 JNJ Competitive Strengths & Weaknesses
7.3 DSK Biopharma
  7.3.1 DSK Biopharma Details
  7.3.2 DSK Biopharma Major Business
  7.3.3 DSK Biopharma Golimumab(Simponi) Product and Services
  7.3.4 DSK Biopharma Golimumab(Simponi) Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.3.5 DSK Biopharma Recent Developments/Updates
  7.3.6 DSK Biopharma Competitive Strengths & Weaknesses

8 RAW MATERIAL AND INDUSTRY CHAIN

8.1 Raw Material of Golimumab(Simponi) and Key Manufacturers
8.2 Golimumab(Simponi) Manufacturing Costs
8.3 Golimumab(Simponi) Production Process
8.4 Golimumab(Simponi) Industrial Chain

9 DISTRIBUTION CHANNEL ANALYSIS

9.1 Distribution Channel Breakdown for Golimumab(Simponi) Shipments (%): 2017-2028
  9.1.1 Direct Channel
  9.1.2 Indirect Channel
9.2 Golimumab(Simponi) Typical Distributors
9.3 Golimumab(Simponi) Typical Customers

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer

LIST OF TABLES

Table 1. World Golimumab(Simponi) Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Golimumab(Simponi) Production Value by Region (2017-2022) & (USD Million)
Table 3. World Golimumab(Simponi) Production Value by Region (2023-2028) & (USD Million)
Table 4. World Golimumab(Simponi) Production Value Market Share by Region (2017-2022)
Table 5. World Golimumab(Simponi) Production Value Market Share by Region (2023-2028)
Table 6. World Golimumab(Simponi) Production by Region (2017-2022) & (Box)
Table 7. World Golimumab(Simponi) Production by Region (2023-2028) & (Box)
Table 8. World Golimumab(Simponi) Production Market Share by Region (2017-2022)
Table 9. World Golimumab(Simponi) Production Market Share by Region (2023-2028)
Table 10. World Golimumab(Simponi) Average Price by Region (2017-2022) & (US$/Box)
Table 11. World Golimumab(Simponi) Average Price by Region (2023-2028) & (US$/Box)
Table 12. Golimumab(Simponi) Major Market Trends
Table 13. World Golimumab(Simponi) Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Box)
Table 14. World Golimumab(Simponi) Consumption by Region (2017-2022) & (Box)
Table 15. World Golimumab(Simponi) Consumption Forecast by Region (2023-2028) & (Box)
Table 16. World Golimumab(Simponi) Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Golimumab(Simponi) Producers in 2021
Table 18. World Golimumab(Simponi) Production by Manufacturer (2017-2022) & (Box)
Table 19. Production Market Share of Key Golimumab(Simponi) Producers in 2021
Table 20. World Golimumab(Simponi) Average Price by Manufacturer (2017-2022) & (US$/Box)
Table 21. Global Golimumab(Simponi) Company Evaluation Quadrant
Table 22. World Golimumab(Simponi) Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Golimumab(Simponi) Production Site of Key Manufacturer
Table 24. Golimumab(Simponi) Market: Company Product Type Footprint
Table 25. Golimumab(Simponi) Market: Company Product Application Footprint
Table 26. Golimumab(Simponi) Competitive Factors
Table 27. Golimumab(Simponi) New Entrant and Capacity Expansion Plans
Table 28. Golimumab(Simponi) Mergers & Acquisitions Activity
Table 29. United States VS China Golimumab(Simponi) Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Golimumab(Simponi) Production Comparison, (2017 & 2021 & 2028) & (Box)
Table 31. United States VS China Golimumab(Simponi) Consumption Comparison, (2017 & 2021 & 2028) & (Box)
Table 32. Major Manufacturer of Golimumab(Simponi) in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Golimumab(Simponi) Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Golimumab(Simponi) Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Golimumab(Simponi) Production by Domestic Manufacturer, (2017-2022) & (Box)
Table 36. United States Golimumab(Simponi) Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Golimumab(Simponi) in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Golimumab(Simponi) Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Golimumab(Simponi) Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Golimumab(Simponi) Production by Domestic Manufacturer, (2017-2022) & (Box)
Table 41. China Golimumab(Simponi) Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Golimumab(Simponi) in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Golimumab(Simponi) Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Golimumab(Simponi) Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Golimumab(Simponi) Production by Domestic Manufacturer, (2017-2022) & (Box)
Table 46. Rest of World Golimumab(Simponi) Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Golimumab(Simponi) Production Value by Specification, (USD Million), 2017 & 2021 & 2028
Table 48. World Golimumab(Simponi) Production by Specification (2017-2022) & (Box)
Table 49. World Golimumab(Simponi) Production by Specification (2023-2028) & (Box)
Table 50. World Golimumab(Simponi) Production Value by Specification (2017-2022) & (USD Million)
Table 51. World Golimumab(Simponi) Production Value by Specification (2023-2028) & (USD Million)
Table 52. World Golimumab(Simponi) Average Price by Specification (2017-2022) & (US$/Box)
Table 53. World Golimumab(Simponi) Average Price by Specification (2023-2028) & (US$/Box)
Table 54. World Golimumab(Simponi) Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Golimumab(Simponi) Production by Application (2017-2022) & (Box)
Table 56. World Golimumab(Simponi) Production by Application (2023-2028) & (Box)
Table 57. World Golimumab(Simponi) Production Value by Application (2017-2022) & (USD Million)
Table 58. World Golimumab(Simponi) Production Value by Application (2023-2028) & (USD Million)
Table 59. World Golimumab(Simponi) Average Price by Application (2017-2022) & (US$/Box)
Table 60. World Golimumab(Simponi) Average Price by Application (2023-2028) & (US$/Box)
Table 61. Chemieliva Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Chemieliva Pharma Major Business
Table 63. Chemieliva Pharma Golimumab(Simponi) Product and Services
Table 64. Chemieliva Pharma Golimumab(Simponi) Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Chemieliva Pharma Recent Developments/Updates
Table 66. Chemieliva Pharma Competitive Strengths & Weaknesses
Table 67. JNJ Basic Information, Manufacturing Base and Competitors
Table 68. JNJ Major Business
Table 69. JNJ Golimumab(Simponi) Product and Services
Table 70. JNJ Golimumab(Simponi) Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. JNJ Recent Developments/Updates
Table 72. DSK Biopharma Basic Information, Manufacturing Base and Competitors
Table 73. DSK Biopharma Major Business
Table 74. DSK Biopharma Golimumab(Simponi) Product and Services
Table 75. DSK Biopharma Golimumab(Simponi) Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 76. Golimumab(Simponi) Raw Material
Table 77. Key Manufacturers of Golimumab(Simponi) Raw Materials
Table 78. Golimumab(Simponi) Typical Distributors
Table 79. Golimumab(Simponi) Typical Customers

LIST OF FIGURES

Figure 1. Golimumab(Simponi) Picture
Figure 2. World Golimumab(Simponi) Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Golimumab(Simponi) Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Golimumab(Simponi) Production (2017-2028) & (Box)
Figure 5. World Golimumab(Simponi) Average Price (2017-2028) & (US$/Box)
Figure 6. World Golimumab(Simponi) Production Value Market Share by Region (2017-2028)
Figure 7. World Golimumab(Simponi) Production Market Share by Region (2017-2028)
Figure 8. North America Golimumab(Simponi) Production (2017-2028) & (Box)
Figure 9. Europe Golimumab(Simponi) Production (2017-2028) & (Box)
Figure 10. China Golimumab(Simponi) Production (2017-2028) & (Box)
Figure 11. Japan Golimumab(Simponi) Production (2017-2028) & (Box)
Figure 12. Golimumab(Simponi) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Golimumab(Simponi) Demand (2017-2028) & (Box)
Figure 15. World Golimumab(Simponi) Consumption Market Share by Region (2017-2028)
Figure 16. United States Golimumab(Simponi) Consumption (2017-2028) & (Box)
Figure 17. China Golimumab(Simponi) Consumption (2017-2028) & (Box)
Figure 18. Europe Golimumab(Simponi) Consumption (2017-2028) & (Box)
Figure 19. Japan Golimumab(Simponi) Consumption (2017-2028) & (Box)
Figure 20. South Korea Golimumab(Simponi) Consumption (2017-2028) & (Box)
Figure 21. ASEAN Golimumab(Simponi) Consumption (2017-2028) & (Box)
Figure 22. India Golimumab(Simponi) Consumption (2017-2028) & (Box)
Figure 23. Producer Shipments of Golimumab(Simponi) by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Golimumab(Simponi) Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Golimumab(Simponi) Markets in 2021
Figure 26. United States VS China: Golimumab(Simponi) Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Golimumab(Simponi) Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Golimumab(Simponi) Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Golimumab(Simponi) in United States
Figure 30. Key Producers and Market Share of Golimumab(Simponi) in China
Figure 31. Key Producers and Market Share of Golimumab(Simponi) in Rest of World
Figure 32. World Golimumab(Simponi) Production Value by Specification, (USD Million), 2017 & 2021 & 2028
Figure 33. World Golimumab(Simponi) Production Value Market Share by Specification in 2021
Figure 34. 100Mg/Ml
Figure 35. 50Mg/Ml
Figure 36. 10Mg/Ml
Figure 37. World Golimumab(Simponi) Production Market Share by Specification (2017-2028)
Figure 38. World Golimumab(Simponi) Production Value Market Share by Specification (2017-2028)
Figure 39. World Golimumab(Simponi) Average Price by Specification (2017-2028) & (US$/Box)
Figure 40. World Golimumab(Simponi) Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Golimumab(Simponi) Production Value Market Share by Application in 2021
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Other
Figure 45. World Golimumab(Simponi) Production Market Share by Application (2017-2028)
Figure 46. World Golimumab(Simponi) Production Value Market Share by Application (2017-2028)
Figure 47. World Golimumab(Simponi) Average Price by Application (2017-2028) & (US$/Box)
Figure 48. Manufacturing Cost Structure Analysis of Golimumab(Simponi) in 2021
Figure 49. Manufacturing Process Analysis of Golimumab(Simponi)
Figure 50. Golimumab(Simponi) Industrial Chain
Figure 51. Distribution Channel Breakdown for Golimumab(Simponi) Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source


More Publications